Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
EPHA1 belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. De plus, nous expédions Ephrin Type A Receptor 1 Kits (30) et Ephrin Type A Receptor 1 Protéines (25) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 161 products:
Human Monoclonal EPHA1 Primary Antibody pour IHC, ELISA - ABIN966070
Pasquale: Eph receptor signalling casts a wide net on cell behaviour. dans Nature reviews. Molecular cell biology 2005
Show all 2 Pubmed References
Human Polyclonal EPHA1 Primary Antibody pour IHC (p), WB - ABIN391884
Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... dans Nature 2003
Show all 3 Pubmed References
Human Polyclonal EPHA1 Primary Antibody pour CyTOF, FACS - ABIN4899970
Gordon, Kochkodan, Blatt, Lin, Kaplan, Johnston, Swindell, Hoover, Schlosser, Elder, Gudjonsson, Getsios: Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis. dans The Journal of investigative dermatology 2013
EphA1 expression is decreased in ovarian serous carcinoma compared with normal fallopian tube and benign ovarian serous cystadenoma. Decreased EphA1 expression was more often detected in high-grade tumors.
High erythropoietin (Montrer EPO Anticorps)-producing hepatocellular carcinoma receptor A (EphA) 1, 2, and 4 expression levels were significantly related to recurrence.
Data show that Ephrin B3 (Montrer EFNB3 Anticorps) was concomitantly expressed with EphA2 (Montrer EPHA2 Anticorps) and Ephrin A1 (Montrer EFNA1 Anticorps) with higher Ephrin B3 (Montrer EFNB3 Anticorps) levels found in non-squamous than in squamous tumors.
Results show that EPHA1 expression is up-regulated in ovarian cancer (OC) cells and provide evidence that it may promote the aggression of some OC cells.
EPHA1 suppresses spreading and adhesion of HRT18 colorectal cancer cells through deactivation of ERK (Montrer EPHB2 Anticorps) and JNK (Montrer MAPK8 Anticorps) signaling pathways.
Data indicate that EphA1 protein may be a new marker for the prognosis of clear cell renal cell carcinoma (Montrer MOK Anticorps).
High expression of EphA1 was associated with metastasis and recurrence in Gastric Cancer.
This study suggests EPHA1 (rs11771145) interferes with the pathological alteration of the hippocampus and the lateral occipitotemporal and inferior temporal gyri throughout the Alzheimer's disease process, leading to a lower risk of Alzheimer's disease.
EphrinA1 plays an important role in the TNF-alpha (Montrer TNF Anticorps)-mediated adhesion of monocytes to endothelial cells.
Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma (Montrer MOK Anticorps).
Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice.
These findings suggest that the ternary complex of EphA, FGFR (Montrer FGFR2 Anticorps) and FRS2alpha (Montrer FRS2 Anticorps) formed by ligand stimulation regulates self-renewal and differentiation of mouse embryonic neural stem/progenitor cells
Whole-mount in situ hybridization revealed overlapping expression of the Epha1 receptor and its high-affinity ligands ephrin A1 (Efna1 (Montrer EFNA1 Anticorps)) and ephrin A3 (Efna3 (Montrer EFNA3 Anticorps)) in the primitive streak and the posterior paraxial mesoderm during early mouse development.
expression of Eph A1, A2, A4, and A7 was strongly detected in endometrial epithelial cells during early pregnancy.
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene is expressed in some human cancer cell lines and has been implicated in carcinogenesis.
eph tyrosine kinase 1
, ephrin type-A receptor 1
, erythropoietin-producing hepatoma amplified sequence
, erythropoietin-producing hepatoma receptor
, oncogene EPH
, soluble EPHA1 variant 1
, soluble EPHA1 variant 2
, tyrosine-protein kinase receptor EPH
, embryonic stem cell kinase
, tyrosine-protein kinase receptor ESK
, ephrin receptor EphA1
, protein tyrosine kinase EphA9